![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Slc25a16 | Mouse | (+)-schisandrin B | multiple interactions | ISO | Slc25a16 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC25A16 mRNA] | CTD | PMID:31150632 | Slc25a16 | Mouse | (1->4)-beta-D-glucan | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC25A16 mRNA | CTD | PMID:36331819 | Slc25a16 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLC25A16 mRNA | CTD | PMID:21570461 | Slc25a16 | Mouse | 2-hydroxypropanoic acid | affects expression | ISO | SLC25A16 (Homo sapiens) | 6480464 | Lactic Acid affects the expression of SLC25A16 mRNA | CTD | PMID:30851411 | Slc25a16 | Mouse | 4,4'-sulfonyldiphenol | decreases methylation | ISO | SLC25A16 (Homo sapiens) | 6480464 | bisphenol S results in decreased methylation of SLC25A16 gene | CTD | PMID:31601247 | Slc25a16 | Mouse | acetamide | decreases expression | ISO | Slc25a16 (Rattus norvegicus) | 6480464 | acetamide results in decreased expression of SLC25A16 mRNA | CTD | PMID:31881176 | Slc25a16 | Mouse | acrylamide | decreases expression | ISO | Slc25a16 (Rattus norvegicus) | 6480464 | Acrylamide results in decreased expression of SLC25A16 mRNA | CTD | PMID:28959563 | Slc25a16 | Mouse | ammonium chloride | affects expression | ISO | Slc25a16 (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of SLC25A16 mRNA | CTD | PMID:16483693 | Slc25a16 | Mouse | amphetamine | increases expression | ISO | Slc25a16 (Rattus norvegicus) | 6480464 | Amphetamine results in increased expression of SLC25A16 mRNA | CTD | PMID:30779732 | Slc25a16 | Mouse | arsenite(3-) | multiple interactions | ISO | SLC25A16 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to SLC25A16 mRNA] | CTD | PMID:32406909 | Slc25a16 | Mouse | benzo[a]pyrene | decreases expression | ISO | SLC25A16 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of SLC25A16 mRNA | CTD | PMID:32234424 | Slc25a16 | Mouse | benzo[a]pyrene diol epoxide I | affects expression | ISO | SLC25A16 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:20018196 | Slc25a16 | Mouse | bisphenol A | affects expression | ISO | Slc25a16 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of SLC25A16 mRNA | CTD | PMID:25181051 | Slc25a16 | Mouse | bisphenol A | decreases expression | ISO | SLC25A16 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of SLC25A16 mRNA | CTD | PMID:33670352 | Slc25a16 | Mouse | bisphenol A | decreases expression | ISO | Slc25a16 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of SLC25A16 mRNA | CTD | PMID:34947998 | Slc25a16 | Mouse | carbon nanotube | increases expression | EXP | | 6480464 | Nanotubes and Carbon results in increased expression of SLC25A16 mRNA | CTD | PMID:25554681 and PMID:25620056 | Slc25a16 | Mouse | ciguatoxin CTX1B | affects expression | EXP | | 6480464 | Ciguatoxins affects the expression of SLC25A16 mRNA | CTD | PMID:18353800 | Slc25a16 | Mouse | copper(II) sulfate | increases expression | ISO | SLC25A16 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of SLC25A16 mRNA | CTD | PMID:19549813 | Slc25a16 | Mouse | cyclosporin A | increases expression | ISO | SLC25A16 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of SLC25A16 mRNA | CTD | PMID:25562108 | Slc25a16 | Mouse | Dibutyl phosphate | affects expression | ISO | SLC25A16 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of SLC25A16 mRNA | CTD | PMID:37042841 | Slc25a16 | Mouse | dorsomorphin | multiple interactions | ISO | SLC25A16 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Slc25a16 | Mouse | elemental selenium | multiple interactions | ISO | SLC25A16 (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in decreased expression of SLC25A16 mRNA | CTD | PMID:19244175 | Slc25a16 | Mouse | elemental selenium | decreases expression | ISO | SLC25A16 (Homo sapiens) | 6480464 | Selenium results in decreased expression of SLC25A16 mRNA | CTD | PMID:19244175 | Slc25a16 | Mouse | epoxiconazole | decreases expression | EXP | | 6480464 | epoxiconazole results in decreased expression of SLC25A16 mRNA | CTD | PMID:35436446 | Slc25a16 | Mouse | formaldehyde | increases expression | ISO | SLC25A16 (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of SLC25A16 mRNA | CTD | PMID:23649840 | Slc25a16 | Mouse | glafenine | decreases expression | ISO | Slc25a16 (Rattus norvegicus) | 6480464 | Glafenine results in decreased expression of SLC25A16 mRNA | CTD | PMID:24136188 | Slc25a16 | Mouse | hydrogen peroxide | increases expression | ISO | SLC25A16 (Homo sapiens) | 6480464 | Hydrogen Peroxide results in increased expression of SLC25A16 mRNA | CTD | PMID:18951874 | Slc25a16 | Mouse | isotretinoin | decreases expression | ISO | SLC25A16 (Homo sapiens) | 6480464 | Isotretinoin results in decreased expression of SLC25A16 mRNA | CTD | PMID:20436886 | Slc25a16 | Mouse | lead diacetate | increases expression | ISO | Slc25a16 (Rattus norvegicus) | 6480464 | lead acetate results in increased expression of SLC25A16 mRNA | CTD | PMID:11578147 | Slc25a16 | Mouse | methapyrilene | decreases expression | ISO | Slc25a16 (Rattus norvegicus) | 6480464 | Methapyrilene results in decreased expression of SLC25A16 mRNA | CTD | PMID:30467583 | Slc25a16 | Mouse | methidathion | decreases expression | EXP | | 6480464 | methidathion results in decreased expression of SLC25A16 mRNA | CTD | PMID:34813904 | Slc25a16 | Mouse | methyl methanesulfonate | increases expression | ISO | SLC25A16 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of SLC25A16 mRNA | CTD | PMID:23649840 | Slc25a16 | Mouse | panobinostat | multiple interactions | ISO | SLC25A16 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A16 mRNA | CTD | PMID:27188386 | Slc25a16 | Mouse | panobinostat | increases expression | ISO | SLC25A16 (Homo sapiens) | 6480464 | panobinostat results in increased expression of SLC25A16 mRNA | CTD | PMID:26272509 | Slc25a16 | Mouse | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of SLC25A16 mRNA | CTD | PMID:17562736 | Slc25a16 | Mouse | paracetamol | increases expression | ISO | Slc25a16 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of SLC25A16 mRNA | CTD | PMID:33387578 | Slc25a16 | Mouse | paracetamol | increases expression | ISO | SLC25A16 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of SLC25A16 mRNA | CTD | PMID:22230336 and PMID:25704631 | Slc25a16 | Mouse | paracetamol | decreases expression | ISO | SLC25A16 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of SLC25A16 mRNA | CTD | PMID:21420995 | Slc25a16 | Mouse | perfluorooctane-1-sulfonic acid | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC25A16 mRNA | CTD | PMID:36331819 | Slc25a16 | Mouse | phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of SLC25A16 mRNA | CTD | PMID:23091169 | Slc25a16 | Mouse | phenylmercury acetate | increases expression | ISO | SLC25A16 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of SLC25A16 mRNA | CTD | PMID:26272509 | Slc25a16 | Mouse | phenylmercury acetate | multiple interactions | ISO | SLC25A16 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A16 mRNA | CTD | PMID:27188386 | Slc25a16 | Mouse | progesterone | increases expression | ISO | SLC25A16 (Homo sapiens) | 6480464 | Progesterone results in increased expression of SLC25A16 mRNA | CTD | PMID:18497975 | Slc25a16 | Mouse | quercetin | decreases expression | ISO | SLC25A16 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of SLC25A16 mRNA | CTD | PMID:21632981 | Slc25a16 | Mouse | rac-lactic acid | affects expression | ISO | SLC25A16 (Homo sapiens) | 6480464 | Lactic Acid affects the expression of SLC25A16 mRNA | CTD | PMID:30851411 | Slc25a16 | Mouse | SB 431542 | multiple interactions | ISO | SLC25A16 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Slc25a16 | Mouse | selenium atom | multiple interactions | ISO | SLC25A16 (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in decreased expression of SLC25A16 mRNA | CTD | PMID:19244175 | Slc25a16 | Mouse | selenium atom | decreases expression | ISO | SLC25A16 (Homo sapiens) | 6480464 | Selenium results in decreased expression of SLC25A16 mRNA | CTD | PMID:19244175 | Slc25a16 | Mouse | sodium arsenite | increases expression | ISO | SLC25A16 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of SLC25A16 mRNA | CTD | PMID:38568856 | Slc25a16 | Mouse | sunitinib | increases expression | ISO | SLC25A16 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of SLC25A16 mRNA | CTD | PMID:31533062 | Slc25a16 | Mouse | tert-butyl hydroperoxide | increases expression | ISO | SLC25A16 (Homo sapiens) | 6480464 | tert-Butylhydroperoxide results in increased expression of SLC25A16 mRNA | CTD | PMID:15336504 | Slc25a16 | Mouse | testosterone | decreases expression | ISO | SLC25A16 (Homo sapiens) | 6480464 | Testosterone results in decreased expression of SLC25A16 mRNA | CTD | PMID:33359661 | Slc25a16 | Mouse | testosterone enanthate | affects expression | ISO | SLC25A16 (Homo sapiens) | 6480464 | testosterone enanthate affects the expression of SLC25A16 mRNA | CTD | PMID:17440010 | Slc25a16 | Mouse | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of SLC25A16 mRNA | CTD | PMID:27339419 and PMID:31919559 | Slc25a16 | Mouse | tetrachloromethane | increases methylation | ISO | Slc25a16 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in increased methylation of SLC25A16 promoter | CTD | PMID:30690589 | Slc25a16 | Mouse | tetrachloromethane | decreases expression | ISO | Slc25a16 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in decreased expression of SLC25A16 mRNA | CTD | PMID:30690589 and PMID:31150632 | Slc25a16 | Mouse | tetrachloromethane | multiple interactions | ISO | Slc25a16 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC25A16 mRNA] | CTD | PMID:31150632 | Slc25a16 | Mouse | thapsigargin | decreases expression | EXP | | 6480464 | Thapsigargin results in decreased expression of SLC25A16 protein | CTD | PMID:24648495 | Slc25a16 | Mouse | valproic acid | affects expression | ISO | SLC25A16 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of SLC25A16 mRNA | CTD | PMID:25979313 | Slc25a16 | Mouse | valproic acid | increases expression | ISO | SLC25A16 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of SLC25A16 mRNA | CTD | PMID:23179753 more ... | Slc25a16 | Mouse | vancomycin | increases expression | EXP | | 6480464 | Vancomycin results in increased expression of SLC25A16 mRNA | CTD | PMID:18930951 | Slc25a16 | Mouse | vitamin E | multiple interactions | ISO | SLC25A16 (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in decreased expression of SLC25A16 mRNA | CTD | PMID:19244175 | Slc25a16 | Mouse | vitamin E | decreases expression | ISO | SLC25A16 (Homo sapiens) | 6480464 | Vitamin E results in decreased expression of SLC25A16 mRNA | CTD | PMID:19244175 | Slc25a16 | Mouse | vorinostat | multiple interactions | ISO | SLC25A16 (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A16 mRNA | CTD | PMID:27188386 | Slc25a16 | Mouse | zidovudine | increases expression | ISO | SLC25A16 (Homo sapiens) | 6480464 | Zidovudine results in increased expression of SLC25A16 mRNA | CTD | PMID:24292225 | |